Abner Herrman & Brock’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-145,500	Closed	-$34K	–	58
2024 Q3	$34K	Hold	145,500	–	–	﹤0.01%	92
2024 Q2	$49K	Hold	145,500	–	–	0.01%	88
2024 Q1	$82K	Hold	145,500	–	–	0.01%	89
2023 Q4	$40K	Hold	145,500	–	–	0.01%	94
2023 Q3	$29K	Sell	145,500 -134,500	-48%	-$26.8K	﹤0.01%	89
2023 Q2	$577K	Hold	280,000	–	–	0.08%	65
2023 Q1	$924K	Hold	280,000	–	–	0.14%	61
2022 Q4	$459K	Hold	280,000	–	–	0.07%	66
2022 Q3	$1.24M	Buy	280,000 +15,000	+6%	+$66.3K	0.23%	48
2022 Q2	$731K	Hold	265,000	–	–	0.13%	53
2022 Q1	$890K	Buy	265,000 +32,000	+14%	+$107K	0.13%	55
2021 Q4	$932K	Buy	233,000 +28,000	+14%	+$112K	0.12%	58
2021 Q3	$676K	Sell	205,000 -36,500	-15%	-$120K	0.1%	61
2021 Q2	$918K	Hold	241,500	–	–	0.13%	57
2021 Q1	$925K	Hold	241,500	–	–	0.14%	61
2020 Q4	$1.09M	Buy	241,500 +1,000	+0.4%	+$4.53K	0.17%	55
2020 Q3	$4.07M	Buy	240,500 +1,500	+0.6%	+$25.4K	0.69%	42
2020 Q2	$2.68M	Buy	239,000 +182,950	+326%	+$2.05M	0.48%	45
2020 Q1	$260K	Buy	+56,050	New	+$260K	0.06%	72